Glimepiride
Sulfonylureas
- Drug class
- Sulfonylureas
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 38
- FDA reports (12 mo)
- 1,237
Overview
Glimepiride is an active pharmaceutical ingredient in the Sulfonylureas group (A10BB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 24 | May 15, 2026 |
| US United States | FDA | 11 | February 26, 2026 |
| CA Canada | Health Canada | 3 | March 22, 2025 |
GBUnited Kingdom· MHRA
24 products
Uses
Glimepiride Tablet is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate.
How to take
USUnited States· FDA
11 products
Uses
1) ]. Limitations of Use Glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. Glimepiride tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( 1 ).
Limitations of Use:
Not for treating type 1 diabetes mellitus or diabetic ketoacidosis ( 1 ).
How to take
CACanada· Health Canada
3 products
Uses
AND CLINICAL USE................................................................................ 3 CONTRAINDICATIONS.................................................................................................... 3 WARNINGS AND PRECAUTIONS ...................................................................................
4 ADVERSE REACTIONS .................................................................................................... 8 DRUG INTERACTIONS...................................................................................................
11 DOSAGE AND ADMINISTRATION................................................................................ 14 OVERDOSAGE ................................................................................................................
16 ACTION AND CLINICAL PHARMACOLOGY ............................................................... 16 STORAGE AND STABILITY ........................................................................................... 20 DOSAGE FORMS, COMPOSITION AND PACKAGING .................................................
Drug interactions
Known interactions involving Glimepiride. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 545. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL157640025 · revised September 6, 2024
- [2]FDA DailyMed · 0003458f-352a-46… · revised November 13, 2024 [PDF]
- [3]Health Canada (DPD) · 02269589 · revised March 22, 2025
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.